Professional
Added to YB: 2026-07-24
Pitch date: 2026-07-20
SOFW.TA [neutral]
SofWave Medical Ltd.
-5.18%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally.
Market Cap
ILS 504.0M
Pitch Price
ILS 43.86
Price Target
N/A
Dividend
N/A
EV/EBITDA
41.32
P/E
73.31
EV/Sales
4.93
Sector
Health Care Equipment and Supplies
Category
growth
Caro-Kann Capital Fund Portfolio Holding - Sofwave Medical
SOFW.TA (holding update): Israeli-listed orphan stock, razor/blade skin-tightening device w/ ~100% GM blades. Rev growth accelerated: 19.7% (4Q24)→57.8% (4Q25), 46%+ 1Q26. Adj EBIT margin flipped -2% (2024) to +10.5% (2025), 16% 4Q25. Insiders own ~25%. GLP-1/Zoom/IG tailwinds, 50%+ US rev.
Read full article (2 min)